SYF571160b7decf4de59000f02126775812Registry ID: 2025-524819-37-00|Not Yet RecruitingPhase 4
Loading search results
interventional
N/A
1 country
3
The primary outcome will be the change in OSA severity from baseline to the 6-month follow-up.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 28, 2025
Actual (reported)The change in Apnea–Hypopnea Index (AHI) at 6 months
OSA pathophysiology (hypoxic burden, delta heart rate, loop gain).
Symptoms (daytime sleepiness).
Blood pressure.
Functional and psychological domains (quality of life, sleep quality, circadian rest-activity rhythm, cognitive function, mental health).
Body weight.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
Wegovy 2.4 mg solution for injection in pre-filled pen
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
SOLUTION FOR INJECTION
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
Wegovy 2.4 mg solution for injection in pre-filled pen
Named ingredient: Semaglutide
View registry recordHospital Clinic De Barcelona
Barcelona, 08036, Spain
Hospital Universitari De Santa Maria
Lleida, 25198, Spain
Hospital Universitario De Guadalajara SESCAM
Guadalajara, 19002, Spain
Diego Arango Del Corro
First Submitted
November 28, 2025
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery
Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
Contact the study team to confirm eligibility.